Medical/Pharmaceuticals
Thrombosis Research Institute (TRI) Launches Innovative Risk Calculator for Predicting Stroke, Major Bleeding and Mortality in Atrial Fibrillation Over Two Years
- Rapidly predicts differences in risk when treated with different anticoagulants or not treated - Crucially, risk is calculated using patient-specific measurements rather than standardised measures, providing personalised results - Underscored by data of 52,000 AF patients and externally vali...
2019-11-21 23:05
2766
Initiation of a Phase 2 Multicenter Study of 18F-APN-1607, a Novel Diagnostic PET Imaging Tracer for the Characterization of Tau Burden in Alzheimer's Disease
TAIPEI, Nov. 21, 2019 /PRNewswire/ -- APRINOIA Therapeutics, Inc. announced today that it has initiated a Phase 2 multicenter, multinational study of18F -APN-1607 in the US for its lead tau positron emission tomography (PET) tracer in Alzheimer's Disease (AD). The study (NCT number: NCT04141150) w...
2019-11-21 23:00
1543
Seed Health Announces Research Partnership with Atmo Biosciences to Evaluate Impact of Probiotics With First Ingestible Gas Sensor Technology
First tech-enabled clinical trial will use new biomarkers to measure effect of Seed's Daily Synbiotic on gut microbiome after antibiotic use LOS ANGELES, Nov. 21, 2019 /PRNewswire/ -- Seed Health, a microbial sciences company, today announced a research partnership with digital health company, At...
2019-11-21 21:00
1298
Global Cord Blood Corporation to Report Second Quarter and First Half Fiscal 2020 Financial Results
HONG KONG, Nov. 21, 2019 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) (the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced that it plans to release unaudited financia...
2019-11-21 20:00
5938
Ascentage Pharma Breaks Ground on its Global Headquarters, R&D Center and Manufacturing Facility in the Suzhou Industrial Park
SUZHOU, China and ROCKVILLE, Md., Nov. 20, 2019 /PRNewswire/ -- Ascentage Pharma (6855.HK), a globally-focused, clinical-stage biotechnology company engaged in developing novel therapies, announced that the groundbreaking ceremony for the Company's global headquarters, R&D center, and manufacturi...
2019-11-21 11:30
1697
Global Cord Blood Corp Comments on New Regulation
HONG KONG, Nov. 20, 2019 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) (the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today commented on a new regulation related to companies in ...
2019-11-20 20:00
5612
NeuroVive Pharmaceutical AB Interim Report January - September 2019
STOCKHOLM, Nov. 20, 2019 /PRNewswire/ -- Important events July - September * NeuroVive initiates second part of its ongoing KL1333 Phase Ia/b clinical study * NeuroSTAT receives Fast Track designation from the US Food and Drug Administration. Financial information third quarter (July-Septem...
2019-11-20 16:38
3930
Covance Receives 2019 Global CRO Customer Value Leadership Award from Frost & Sullivan
SINGAPORE, Nov. 20, 2019 /PRNewswire/ -- Covance was honored with the 2019 Global CRO Customer Value Leadership award from Frost & Sullivan at the annual Frost & Sullivan Asia-Pacific Best Practices Awards banquet held inSingapore on 14 November 2019. Frost & Sullivan firmly believes Covance's e...
2019-11-20 15:52
1065
Cambridge Quantum Computing Achieves Groundbreaking Results in Quantum Chemistry
CQC gets VQE "off the ground" and provides an efficient route towards simulating excited molecules using quantum computers CAMBRIDGE, England, Nov. 20, 2019 /PRNewswire/ -- Cambridge Quantum Computing ("CQC") today announced an important breakthrough in quantum chemistry that will enhance and ac...
2019-11-20 15:00
2334
Merck Announces Orphan Drug Designation for Investigational Therapy Tepotinib in Patients with NSCLC Harboring MET Gene Alterations
- Japanese Ministry of Health, Labour and Welfare grants orphan drug designation for diseases that affect fewer than 50,000 patients inJapan, and for which significant unmet medical need exists - MET exon 14 (METex14) skipping alterations and MET amplifications are present in 3-5% of non-small c...
2019-11-20 15:00
2287
CStone announces first patient dosed in the Phase I bridging registrational study of ivosidenib
SUZHOU, China, Nov. 20, 2019 /PRNewswire/ -- CStone Pharmaceuticals ("CStone" or the "Company", HKEX: 2616) today announced that the first patient has been dosed in the Phase I bridging registrational study of ivosidenib (TIBSOVO®) in China. This stand-alone trial is designed to validate the effi...
2019-11-20 11:41
2293
Excelra Announces a Drug Repurposing Collaboration With Maruho On Dermatological Applications
HYDERABAD, India, Nov. 20, 2019 /PRNewswire/ -- Excelra, a leading global Data and Analytics Company today announced a Drug Repurposing collaboration withOsaka -based Maruho – a pharmaceutical company specialising in Dermatology. Under the agreement, the Drug Repurposing Data Scientists and Therap...
2019-11-20 10:00
2238
Potential New Biomarkers for Parkinson's Disease Could Change Trajectory of Diagnosis and Treatment
LONDON, Nov. 20, 2019 /PRNewswire/ -- World Federation of Neurology: A groundbreaking presentation coming out of theXXIV World Congress of Neurology (WCN 2019) inDubai, UAE, highlighted several significant advances in Parkinson's research. "We are beginning to understand Parkinson's disease mech...
2019-11-20 02:27
1044
Burning Rock Dx Launches Magnis BR to Innovate Total Process Automation for NGS Testing
ZHENGZHOU, Nov. 19, 2019 /PRNewswire/ -- Today, Agilent Technologies and Guangzhou Burning Rock Medical Laboratory Co., Ltd. ("Burning Rock Dx") jointly held a product launch event on Magnis BR, an automated next generation sequencing (NGS) library preparation system, to announce that Magnis BR i...
2019-11-19 21:00
1485
Edan to Highlight Its New Developments at MEDICA 2019
DUSSELDORF, Germany, Nov. 19, 2019 /PRNewswire/ -- Edan, a healthcare solutions provider, revealed their latest product series in its all five product lines, including Obstetrics and Gynecology, Patient Monitoring, In-Vitro Diagnostics, Diagnostic ECG, and Ultrasound, bringing a huge surprise to ...
2019-11-19 18:18
1280
Pregnancy No Longer Believed to Modify Trajectory of MS, Experts Say
LONDON, Nov. 18, 2019 /PRNewswire/ -- World Federation of Neurology — For women living with MS, pregnancy, and breastfeeding were once thought to slow the progression of the disease. During theXXIV World Congress of Neurology (WCN 2019) inDubai, UAE, which took place Oct. 27-31, 2019, experts re...
2019-11-18 23:30
1420
The Prognosis for MS is Changing Due to Advancements in Treatment and Awareness, Yet Access to Care is Top of Mind for Global Neurologists
LONDON, Nov. 18, 2019 /PRNewswire/ -- World Federation of Neurology: Are regulators keeping up with new treatments and management strategies that can greatly improve the lives of patients with multiple sclerosis (MS)? That question is being debated following the unveiling of significant clinical ...
2019-11-18 23:28
1357
Clarity Engagement Solutions announces the appointment of Kevin Simpson as CEO
DUBLIN, Nov. 18, 2019 /PRNewswire/ -- Clarity Engagement Solutions, a leading provider of performance consulting, training and execution in the life sciences, medical device and corporate and institutional banking industries today announced that the Company's Board of Directors has appointedKevin...
2019-11-18 23:26
1801
RhoVac Reports Interim Results on Immunological Response with RV001
STOCKHOLM, Nov. 18, 2019 /PRNewswire/ -- Today, 18th November 2019, RhoVac AB ("RhoVac") reports interim results from ongoing immunological studies at University of Tübingen,Germany concluding that treatment with RV001 can activate CD4+ T-cells and also CD8+ T-cells. In July 2019 RhoVac publishe...
2019-11-18 17:13
1091
3SBio Selects Verseau's PSGL-1-targeted Antibody VTX-0811 as First Partnered Macrophage Checkpoint Modulator in Immuno-Oncology Collaboration
SHENYANG, China and BEDFORD Mass., Nov. 17, 2019 /PRNewswire/ -- 3SBio Inc.
2019-11-18 08:30
4186
Week's Top Stories
Most Reposted
Alpha Trading Cup 2024 Award Night: Top Trader Achieves Remarkable 315% Profit, as Over 1,149 Competitors Vie for USD 44,000 Prize Pool
[Picked up by 313 media titles]
2024-10-25 18:29
International Golo Mori Jazz 2024: Experience the Harmony of Eastern Indonesia's Exotic Beauty and Romantic Jazz Music
[Picked up by 300 media titles]
2024-10-25 22:48
2024 Malaysia E-commerce Product Selection Expo Reaches Major Milestone Attracting Leading Brands and Businesses From China
[Picked up by 300 media titles]
2024-10-25 07:00
RuggON Showcases Latest Mining Technology at IMARC 2024
[Picked up by 297 media titles]
2024-10-28 14:32
TotalEnergies ENEOS Completes a 1.8 MWp Floating Solar Photovoltaic System Project, a Second Collaboration with S. Kijchai Enterprise in Thailand
[Picked up by 288 media titles]
2024-10-29 11:24
Most Read
Alpha Trading Cup 2024 Award Night: Top Trader Achieves Remarkable 315% Profit, as Over 1,149 Competitors Vie for USD 44,000 Prize Pool
2024-10-25 18:29
8610
International Golo Mori Jazz 2024: Experience the Harmony of Eastern Indonesia's Exotic Beauty and Romantic Jazz Music
2024-10-25 22:48
7462
Infobip and Singtel Partner to Advance Customer Engagement for Singapore Businesses with Rich Communication Services
2024-10-25 12:30
7039
Global development relies on cooperation
2024-10-25 12:38
6056
Peak Energy CEO Gavin Adda Speaks at Asia Clean Energy Summit 2024
2024-10-25 18:30
5759
